Загрузка...
Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis
BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...
Сохранить в:
| Опубликовано в: : | Oncologist |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AlphaMed Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/ https://ncbi.nlm.nih.gov/pubmed/29330211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|